NDC 80425-0121-01 - Cephalexin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0121
- Requested NDC
- 80425-0121-01
- Package NDCs from labels
- 80425-0121-4, 80425-0121-1, 80425-0121-2, 80425-0121-3, 80425-0121-5, 80425-0121-6, 80425-0121-7, 80425-0121-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-01-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cephalexin - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-01-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0121-1 | Cephalexin | 28 in 1 BOTTLE | CAPSULE | 28 | 10 | |
| 80425-0121-2 | Cephalexin | 40 in 1 BOTTLE | CAPSULE | 40 | 10 | |
| 80425-0121-3 | Cephalexin | 30 in 1 BOTTLE | CAPSULE | 30 | 10 | |
| 80425-0121-4 | Cephalexin | 20 in 1 BOTTLE | CAPSULE | 20 | 10 | |
| 80425-0121-5 | Cephalexin | 14 in 1 BOTTLE | CAPSULE | 14 | 10 | |
| 80425-0121-6 | Cephalexin | 5 in 1 BOTTLE | CAPSULE | 5 | 10 | |
| 80425-0121-7 | Cephalexin | 6 in 1 BOTTLE | CAPSULE | 6 | 10 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0121 | CEPHALEXIN CAPSULE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 10 | Current NDC, Legacy NDC, 7 package rows | 20240119_b6ffe633-dd91-6d49-e053-2a95a90a5ac6.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0121-1 | EA - Each | 80425-0121 | b098bd7f-bb96-4b61-a21d-97eace448f0c | 1 | 2023-03-13 |
| 80425-0121-2 | EA - Each | 80425-0121 | 426ea2b8-26c1-43e8-a5b1-1672b92f5233 | 1 | 2023-03-13 |
| 80425-0121-3 | EA - Each | 80425-0121 | 7fc1df44-2cd9-4b79-ae4c-de04aadf60a9 | 1 | 2023-03-13 |
| 80425-0121-4 | EA - Each | 80425-0121 | 565cd629-53b3-43a8-a2d5-ea15be49d06e | 1 | 2023-03-13 |
| 80425-0121-5 | EA - Each | 80425-0121 | d48bfbc1-a630-44dc-a60e-afcb09a91657 | 1 | 2023-03-13 |
| 80425-0121-6 | EA - Each | 80425-0121 | 2aca4026-c892-49c5-a382-fcec45451772 | 1 | 2023-10-16 |
| 80425-0121-7 | EA - Each | 80425-0121 | dd7a169c-9ad3-407c-8d7b-6183f03ecc0e | 1 | 2024-06-10 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cephalexin | CEPHALEXIN | A-S Medication Solutions | ee0603a5-0758-4968-89e3-1aa95e9967f2 | 2023-12-12 | Warnings, Adverse reactions | ANDA090836 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | 18518154-30ba-48a4-852a-3a7723030071 | 2023-12-07 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| cephalexin | CEPHALEXIN | Proficient Rx LP | 829244bd-93da-4a5a-a257-890cfec4c06d | 2023-12-01 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Major Pharmaceuticals | 1c1fbad7-bef4-42a0-a8c9-b35168f5d533 | 2023-11-07 | Warnings, Adverse reactions | ANDA090836 309114 309112 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | 2cb7bc3a-988b-4414-8036-fb09b2ab5767 | 2023-10-23 | Warnings, Adverse reactions | ANDA090836 309112 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | b270d537-878b-4468-b246-b704adb29ced | 2023-10-23 | Warnings, Adverse reactions | ANDA090836 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Teva Pharmaceuticals USA, Inc. | 445b2a87-2e4f-483a-abe8-26fefd67514a | 2023-10-01 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Asclemed USA, Inc. | 8073f183-e11f-41af-8bd1-1505bc7e044b | 2023-09-01 | Warnings, Adverse reactions | ANDA090836 309114 637173 645617 309112 OBN7UDS42Y |
| cephalexin | CEPHALEXIN | A-S Medication Solutions | 0a24b6e5-6f13-44b4-93f4-47c86945cad2 | 2023-04-26 | Warnings, Adverse reactions | OBN7UDS42Y |
| CEPHALEXIN | CEPHALEXIN | DIRECT RX | 2d12e6a9-f7dd-25ed-e054-00144ff8d46c | 2022-09-29 | Warnings, Adverse reactions | ANDA090836 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Asclemed USA, Inc. | 6032b68f-16d8-41b6-bd2c-86d5406a757a | 2022-09-21 | Warnings, Adverse reactions | 309114 309112 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Asclemed USA, Inc. | 891b8c0e-dbf4-4b0e-ba3f-c4c49d51510d | 2022-07-20 | Warnings, Adverse reactions | ANDA090836 309112 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Proficient Rx LP | febab51b-6b48-488a-8fd1-d24400e5df1d | 2022-07-01 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Proficient Rx LP | dec3a1ef-1e85-4236-804b-e7a343d3a58f | 2022-05-02 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Proficient Rx LP | ada7b8a5-98f4-454c-b38f-92192d4db33f | 2021-08-01 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Pharma-C, Inc. | bf9a6c06-11fd-4fb7-9cf5-e8e787758c1c | 2016-12-09 | Warnings, Adverse reactions | 309114 309112 OBN7UDS42Y |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.